Source: International Business Times
More than three decades ago, a discovery rooted in Nigeria's natural landscape began a journey that would evolve into a focused pharmaceutical effort addressing one of the most pressing unmet needs in modern medicine. Immune Modulation, Inc. , a California-based biotech company founded in 1995, is built around that journey, translating a plant-derived compound into a drug candidate now being prepared for regulatory pathways in Parkinson's disease.
Go to Source
Related News
